摘要
目的对坎地沙坦酯用于预防和治疗偏头痛的疗效及安全性进行探讨。方法选取2016年1月—2017年1月来我院就诊的64例偏头痛患者作为研究对象。按照随机数字表,将其分为A、B两组,每组均为32例。A组患者予以盐酸氟桂利嗪,B组患者予以坎地沙坦酯进行治疗。结果经过治疗后,与A组对比,B组患者头痛时间更短、总治疗有效率更高、不良反应更低,差异均具有统计学意义(P<0.05)。结论坎地沙坦酯对于预防和治疗偏头痛的疗效及安全性高。
Objective To study the efficacy and safety of candesartan cilexetil in the prevention and treatment of migraine. Methods A total of 64 migraine patients were selected from January 2016 to January 2017. A group was treated with flunarizine hydrochloride, B group of patients treated with candesartan treatment. Results After treatment, compared with the A group, the B group had shorter headache time, higher total treatment efficiency and lower adverse reactions, the difference was statistically significant （P〈0.05）. Conclusion The efficacy and safety of candesartan cilexetil in the prevention and treatment of migraine are high. and worthy of popularization and application in clinical practice.
出处
《中国继续医学教育》
2017年第11期158-159,共2页
China Continuing Medical Education
关键词
坎地沙坦酯
预防治疗
偏头痛
临床效果
candesartan palmitate
prevention and treatment
migraine
clinical effect
